Manganese-doped nanotheranostic system for MRI-guided photothermal therapy of malignant pleural mesothelioma: <i>in vivo</i> study. [PDF]
Lei L +7 more
europepmc +1 more source
Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma. [PDF]
Mosleh B +13 more
europepmc +1 more source
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [PDF]
Felip, E. +3 more
core
Case Report: IL-6 suppression: a potential strategy for mitigating severe immune-related adverse events in nivolumab and ipilimumab therapy for malignant pleural mesothelioma. [PDF]
Yanagisawa A +4 more
europepmc +1 more source
Immunotherapy for advanced and recurrent malignant pleural mesothelioma. [PDF]
Haugaard AK +5 more
europepmc +1 more source
Prognostic Value of Chest CT Volumetric Analysis in Patients with Malignant Pleural Mesothelioma. [PDF]
Baratella E +9 more
europepmc +1 more source
Related searches:
Malignant Pleural Mesothelioma
Current Oncology Reports, 2011Malignant pleural mesothelioma (MPM) is a relatively rare thoracic malignancy accounting for about 2000-3000 new cases per year. This cancer has been increasing in incidence and is strongly associated with asbestos exposure. Also, it is characterized by insidious growth and clinical presentation at an advanced stage of disease.
Siva, Raja +2 more
openaire +2 more sources
Malignant Pleural Mesothelioma
The American Journal of the Medical Sciences, 2005Malignant pleural mesothelioma is an uncommon tumor; only about 3000 cases are diagnosed annually in the United States. Cases were described early in the 20th century, but their relationship to asbestos exposure was not documented until 1960. Since then, the incidence has appeared to increase, and numerous epidemiologic studies have confirmed that ...
Norman M. Kaplan +2 more
openaire +2 more sources

